These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31472062)

  • 1. The effect of GnRH analogue treatment on bone mineral density in young adolescents with gender dysphoria: findings from a large national cohort.
    Joseph T; Ting J; Butler G
    J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1077-1081. PubMed ID: 31472062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones.
    Schagen SEE; Wouters FM; Cohen-Kettenis PT; Gooren LJ; Hannema SE
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4252-63. PubMed ID: 32909025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term outcomes of pubertal suppression in a selected cohort of 12 to 15 year old young people with persistent gender dysphoria in the UK.
    Carmichael P; Butler G; Masic U; Cole TJ; De Stavola BL; Davidson S; Skageberg EM; Khadr S; Viner RM
    PLoS One; 2021; 16(2):e0243894. PubMed ID: 33529227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pubertal Suppression, Bone Mass, and Body Composition in Youth With Gender Dysphoria.
    Navabi B; Tang K; Khatchadourian K; Lawson ML
    Pediatrics; 2021 Oct; 148(4):. PubMed ID: 34497118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents.
    Vlot MC; Klink DT; den Heijer M; Blankenstein MA; Rotteveel J; Heijboer AC
    Bone; 2017 Feb; 95():11-19. PubMed ID: 27845262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized evaluation of lumbar bone mineral density and bone mineral apparent density in children and adolescents.
    Duran I; Martakis K; Rehberg M; Semler O; Schoenau E
    Arch Osteoporos; 2018 Oct; 13(1):117. PubMed ID: 30374788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
    Lem AJ; van der Kaay DC; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mass in young adulthood following gonadotropin-releasing hormone analog treatment and cross-sex hormone treatment in adolescents with gender dysphoria.
    Klink D; Caris M; Heijboer A; van Trotsenburg M; Rotteveel J
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E270-5. PubMed ID: 25427144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical changes, laboratory parameters, and bone mineral density during testosterone treatment in adolescents with gender dysphoria.
    Stoffers IE; de Vries MC; Hannema SE
    J Sex Med; 2019 Sep; 16(9):1459-1468. PubMed ID: 31405768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty.
    Boot AM; De Muinck Keizer-Schrama S; Pols HA; Krenning EP; Drop SL
    J Clin Endocrinol Metab; 1998 Feb; 83(2):370-3. PubMed ID: 9467543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Adrenal Androgens During Puberty Suppression and Gender-Affirming Hormone Treatment in Adolescents With Gender Dysphoria.
    Schagen SEE; Lustenhouwer P; Cohen-Kettenis PT; Delemarre-van de Waal HA; Hannema SE
    J Sex Med; 2018 Sep; 15(9):1357-1363. PubMed ID: 30224022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone density in adolescents treated with a GnRH agonist and add-back therapy for endometriosis.
    Divasta AD; Laufer MR; Gordon CM
    J Pediatr Adolesc Gynecol; 2007 Oct; 20(5):293-7. PubMed ID: 17868896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy.
    van der Sluis IM; Boot AM; Krenning EP; Drop SL; de Muinck Keizer-Schrama SM
    J Clin Endocrinol Metab; 2002 Feb; 87(2):506-12. PubMed ID: 11836277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotropin-Releasing Hormone Agonist Therapy and Longitudinal Bone Mineral Density in Congenital Adrenal Hyperplasia.
    Flokas ME; Wakim P; Kollender S; Sinaii N; Merke DP
    J Clin Endocrinol Metab; 2024 Jan; 109(2):498-504. PubMed ID: 37643900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral density by age, gender, pubertal stages, and socioeconomic status in healthy Lebanese children and adolescents.
    Arabi A; Nabulsi M; Maalouf J; Choucair M; Khalifé H; Vieth R; El-Hajj Fuleihan G
    Bone; 2004 Nov; 35(5):1169-79. PubMed ID: 15542043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone Mineral Density in Transgender Adolescents Treated With Puberty Suppression and Subsequent Gender-Affirming Hormones.
    van der Loos MATC; Vlot MC; Klink DT; Hannema SE; den Heijer M; Wiepjes CM
    JAMA Pediatr; 2023 Dec; 177(12):1332-1341. PubMed ID: 37902760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Puberty suppression in adolescents with gender dysphoria: an emerging issue with multiple implications.
    Betsi G; Goulia P; Sandhu S; Xekouki P
    Front Endocrinol (Lausanne); 2024; 15():1309904. PubMed ID: 38988996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lumbar Spine Bone Mineral Apparent Density in Children: Results From the Bone Mineral Density in Childhood Study.
    Kindler JM; Lappe JM; Gilsanz V; Oberfield S; Shepherd JA; Kelly A; Winer KK; Kalkwarf HJ; Zemel BS
    J Clin Endocrinol Metab; 2019 Apr; 104(4):1283-1292. PubMed ID: 30265344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal and femoral bone mass accumulation during normal adolescence: comparison with female patients with sexual precocity and with hypogonadism.
    Takahashi Y; Minamitani K; Kobayashi Y; Minagawa M; Yasuda T; Niimi H
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1248-53. PubMed ID: 8772607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Children and adolescents in the Amsterdam Cohort of Gender Dysphoria: trends in diagnostic- and treatment trajectories during the first 20 years of the Dutch Protocol.
    van der Loos MATC; Klink DT; Hannema SE; Bruinsma S; Steensma TD; Kreukels BPC; Cohen-Kettenis PT; de Vries ALC; den Heijer M; Wiepjes CM
    J Sex Med; 2023 Feb; 20(3):398-409. PubMed ID: 36763938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.